924 related articles for article (PubMed ID: 24553434)
1. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.
Liu S; Soong Y; Seshan SV; Szeto HH
Am J Physiol Renal Physiol; 2014 May; 306(9):F970-80. PubMed ID: 24553434
[TBL] [Abstract][Full Text] [Related]
2. Improving mitochondrial bioenergetics under ischemic conditions increases warm ischemia tolerance in the kidney.
Szeto HH; Liu S; Soong Y; Birk AV
Am J Physiol Renal Physiol; 2015 Jan; 308(1):F11-21. PubMed ID: 25339695
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.
Birk AV; Liu S; Soong Y; Mills W; Singh P; Warren JD; Seshan SV; Pardee JD; Szeto HH
J Am Soc Nephrol; 2013 Jul; 24(8):1250-61. PubMed ID: 23813215
[TBL] [Abstract][Full Text] [Related]
4. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells.
Cantaluppi V; Gatti S; Medica D; Figliolini F; Bruno S; Deregibus MC; Sordi A; Biancone L; Tetta C; Camussi G
Kidney Int; 2012 Aug; 82(4):412-27. PubMed ID: 22495296
[TBL] [Abstract][Full Text] [Related]
5. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.
Szeto HH
Br J Pharmacol; 2014 Apr; 171(8):2029-50. PubMed ID: 24117165
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 protects mice against renal ischemia-reperfusion injury by reducing inflammation and improving endothelial function.
Zhou S; Jiang S; Guo J; Xu N; Wang Q; Zhang G; Zhao L; Zhou Q; Fu X; Li L; Patzak A; Hultström M; Lai EY
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F134-F145. PubMed ID: 30461292
[TBL] [Abstract][Full Text] [Related]
7. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury.
Jung YJ; Kim DH; Lee AS; Lee S; Kang KP; Lee SY; Jang KY; Sung MJ; Park SK; Kim W
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F952-60. PubMed ID: 19656917
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1
Szeto HH; Liu S; Soong Y; Seshan SV; Cohen-Gould L; Manichev V; Feldman LC; Gustafsson T
J Am Soc Nephrol; 2017 May; 28(5):1437-1449. PubMed ID: 27881606
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.
Szeto HH; Liu S; Soong Y; Wu D; Darrah SF; Cheng FY; Zhao Z; Ganger M; Tow CY; Seshan SV
J Am Soc Nephrol; 2011 Jun; 22(6):1041-52. PubMed ID: 21546574
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
[TBL] [Abstract][Full Text] [Related]
11. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis.
Birk AV; Chao WM; Bracken C; Warren JD; Szeto HH
Br J Pharmacol; 2014 Apr; 171(8):2017-28. PubMed ID: 24134698
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
[TBL] [Abstract][Full Text] [Related]
13. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
[No Abstract] [Full Text] [Related]
14. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
[TBL] [Abstract][Full Text] [Related]
15. Renal oxygenation in acute renal ischemia-reperfusion injury.
Abdelkader A; Ho J; Ow CP; Eppel GA; Rajapakse NW; Schlaich MP; Evans RG
Am J Physiol Renal Physiol; 2014 May; 306(9):F1026-38. PubMed ID: 24598805
[TBL] [Abstract][Full Text] [Related]
16. miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction.
Douvris A; Viñas JL; Gutsol A; Zimpelmann J; Burger D; Burns KD
Clin Sci (Lond); 2024 May; 138(10):599-614. PubMed ID: 38739452
[TBL] [Abstract][Full Text] [Related]
17. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury.
Lech M; Römmele C; Gröbmayr R; Eka Susanti H; Kulkarni OP; Wang S; Gröne HJ; Uhl B; Reichel C; Krombach F; Garlanda C; Mantovani A; Anders HJ
Kidney Int; 2013 Apr; 83(4):647-61. PubMed ID: 23325083
[TBL] [Abstract][Full Text] [Related]
18. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
[TBL] [Abstract][Full Text] [Related]
19. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury.
Lan S; Yang B; Migneault F; Turgeon J; Bourgault M; Dieudé M; Cardinal H; Hickey MJ; Patey N; Hébert MJ
Am J Physiol Renal Physiol; 2021 Sep; 321(3):F335-F351. PubMed ID: 34338031
[TBL] [Abstract][Full Text] [Related]
20. Meclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury.
Kishi S; Campanholle G; Gohil VM; Perocchi F; Brooks CR; Morizane R; Sabbisetti V; Ichimura T; Mootha VK; Bonventre JV
EBioMedicine; 2015 Sep; 2(9):1090-101. PubMed ID: 26501107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
